#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	11998	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2052	578.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1408	1408	C	681	C	636	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22232	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3751	590.5	0	.	n	.	0	T695C	SNP	695	695	T	1197	1197	C	611	C,T	567,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22232	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3751	590.5	0	.	n	.	0	A1638G	SNP	1638	1638	A	2140	2140	G	734	G	672	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22232	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3751	590.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2473	2473	C	654	C,G	615,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22232	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3751	590.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2547	2547	A	733	A	690	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22232	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3751	590.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3099	3099	C	665	C	622	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	283	1698	folP	855	855	100.0	folP.l6.c30.ctg.1	1763	95.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1134	1136	AGC	169;166;167	A;G;C	165;163;164	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4218	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3435	122.0	1	SNP	p	S91F	1	.	.	271	273	TTC	631	633	TTC	142;140;139	T;T;C	133;130;129	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4218	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3435	122.0	1	SNP	p	G95N	0	.	.	283	285	GGC	643	645	GGC	139;143;144	G;G;C	127;132;133	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4218	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3435	122.0	1	SNP	p	D95G	1	.	.	283	285	GGC	643	645	GGC	139;143;144	G;G;C	127;132;133	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1394	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1261	109.8	1	SNP	p	G45D	0	.	.	133	135	GGC	445	447	GGC	183;183;187	G;G;C	167;164;172	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	674	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1066	63.0	0	.	n	.	0	A197.	DEL	197	197	A	581	581	A	154	A	149	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2805	157.4	1	SNP	p	D86N	0	.	.	256	258	GAC	498	500	GAC	163;165;166	G;A;C	154;152;158	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2805	157.4	1	SNP	p	R87I	0	.	.	259	261	CGT	501	503	CGT	170;170;168	C;G;T	163;156;152	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2805	157.4	1	SNP	p	R87W	0	.	.	259	261	CGT	501	503	CGT	170;170;168	C;G;T	163;156;152	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2805	157.4	1	SNP	p	S87R	1	.	.	259	261	CGT	501	503	CGT	170;170;168	C;G;T	163;156;152	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4448	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2805	157.4	1	SNP	p	S88P	0	.	.	262	264	TCC	504	506	TCC	169;168;169	T;C;C	158;157;161	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3636	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2829	127.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1604	1606	GGC	177;175;177	G;G;C	168;166;170	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1284	1286	GCC	203;201;202	G;C;C	191;191;192	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1287	1289	ATG	205;208;206	A;T;G	196;199;194	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1299	1301	ACC	201;203;200	A;C;C	192;193;191	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1299	1301	ACC	201;203;200	A;C;C	192;193;191	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1800	1802	ACC	205;204;205	A;C;C	186;188;188	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1854	1856	GCG	190;190;192	G;C;G	181;179;179	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1854	1856	GCG	190;190;192	G;C;G	181;179;179	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1977	1979	GGT	159;156;157	G;G;T	144;144;142	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1986	1988	AGC	149;146;144	A;G;C	134;133;131	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3568	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2509	141.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2004	2006	CCG	130;133;134	C,G;C,G;G	98,6;102,1;104	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5154	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3128	163.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1658	1660	CCG	191;187;188	C;C;G	171;174;168	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1952	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1731	112.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	484	484	C	135	C	128	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1622	156.0	0	.	p	.	0	I45V	NONSYN	133	135	ATT	455	457	GTT	224;225;224	G;T;T	204;201;204	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1622	156.0	0	.	p	.	0	N294D	NONSYN	880	882	AAC	1202	1204	GAC	198;197;199	G;A;C	181;183;183	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1622	156.0	1	SNP	p	G120K	1	.	.	358	360	AAG	680	682	AAG	219;219;221	A;A;G	197;198;196	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1622	156.0	1	SNP	p	N121D	0	.	.	361	363	AAC	683	685	AAC	219;218;217	A;A;C	199;196;193	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1622	156.0	1	SNP	p	A121N	1	.	.	361	363	AAC	683	685	AAC	219;218;217	A;A;C	199;196;193	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10132	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4869	207.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1044	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	962	107.2	1	SNP	p	V57M	1	.	.	169	171	ATG	476	478	ATG	212;210;209	A;T;G	199;197;196	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
